Oncotarget Publishes New Data by Lantern Pharma

Non-Hodgkin’s lymphoma (NHL) is the seventh leading cause of cancer in the US, with 20-40% of patients experiencing relapsed or refractory disease with limited or no therapeutic options. Publication highlights in vitro and in vivo results supporting LP-284’s development for mantle cell lymphoma (MCL), an aggressive form of B-cell non-Hodgkin’s...

The post Oncotarget Publishes New Data by Lantern Pharma first appeared on AI-TechPark.

cancer data development disease highlights machine learning patients pharma publication